Merix and Kirin Collaborate on Dendritic Cell Vaccine Development
By Business Review Editor
Pharma Deals Review: Vol 2004 Issue 50 (Table of Contents)
Published: 4 Aug-2004
DOI: 10.3833/pdr.v2004.i50.786 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Merix and Kirin entered into a collaboration to co-develop dendritic cell vaccines for treating variety of diseases including cancer, infectious disease, autoimmune disorders and transplantation...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS